[
  {
    "﻿TEST NAME": "4D Lifetest Lung Dx",
    "COMPANY ": "4D Lifetec",
    "LINK": "https://4dlifetec.com/cancer-detect-test/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "DDS (DNA gamage)",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Notes": "Clinical validation for lung, breast, prostate, colon in Switzerland underway",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "Lung",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ROCA",
    "COMPANY ": "Abcodia",
    "LINK": "www.therocatest.co.uk",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Ovarian",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "BRCA1/BRCA2",
    "TARGET": "CA-125",
    "Dev. Stage": "Available by request ",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "BRCA1 or BRCA2 mutation",
    "ACTION": "Txt Guidance",
    "CANCER TYPE": "Ovarian",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "UK only",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "GemciTest",
    "COMPANY ": "Acobiom",
    "LINK": "https://www.acobiom.com/en/gemcitest-first-predictive-diagnostic-test-in-pancreatic-cancer/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Pancreatic",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "For metastatic panc. Cancer, determine if gem is good first line",
    "Requirements": "",
    "ACTION": "Txt Guidance (Gemcitabine)",
    "CANCER TYPE": "Pancreatic Adeno (met)",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "France",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ACT Monitor Colon",
    "COMPANY ": "ACT Genomics",
    "LINK": "https://www.actgenomics.com/tests-professional/actmonitor-colon",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (recurrance)",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ACT Monitor Breast",
    "COMPANY ": "ACT Genomics",
    "LINK": "https://www.actgenomics.com/tests-professional/actmonitor-breast",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Breast",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (recurrance)",
    "CANCER TYPE": "Breast",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ACT Monitor Lung",
    "COMPANY ": "ACT Genomics",
    "LINK": "https://www.actgenomics.com/tests-professional/actmonitor-lung",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (recurrance)",
    "CANCER TYPE": "Lung",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ACT Monitor +",
    "COMPANY ": "ACT Genomics",
    "LINK": "https://actgenomics.webflow.io/tests-professional/actmonitor",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Solid Tumors",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (recurrance)",
    "CANCER TYPE": "Solid Tumors",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ACT Cerebra",
    "COMPANY ": "ACT Genomics",
    "LINK": "https://actgenomics.webflow.io/tests-professional/actcerebra",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Brain",
    "FLUID TYPE": "CSF",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "cfDNA",
    "Appl. Genes": "",
    "TARGET": "cfDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "8 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Profiling",
    "CANCER TYPE": "Brain (met)",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ACT Liquid PRO",
    "COMPANY ": "ACT Genomics",
    "LINK": "https://www.actgenomics.com/tests-professional/actliquid",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Solid Tumors",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "7 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Txt Guidance (Gene Based)",
    "CANCER TYPE": "Pan-Solid Tumors",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "PreveCol",
    "COMPANY ": "Amadix",
    "LINK": "https://amadix.com/prevecol/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "Yes ",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Malignancy Assessment (Primary)",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "450 euro",
    "Location": "Spain",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "DiagnoLung",
    "COMPANY ": "Amadix",
    "LINK": "https://amadix.com/diagnolung/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Malignancy Assessment (Primary)",
    "CANCER TYPE": "Lung",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "PancreaDix",
    "COMPANY ": "Amadix",
    "LINK": "https://amadix.com/pancreadix/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Pancreatic",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Malignancy Assessment (Primary)",
    "CANCER TYPE": "Pancreatic",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ADXBladder",
    "COMPANY ": "Arquer Diagnostics",
    "LINK": "https://arquerdx.com/our-tests/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Bladder",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "MCM5",
    "Dev. Stage": "",
    "Turnaround Time ": "3 hours",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (recurrance)",
    "CANCER TYPE": "Bladder",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "OvaWatch",
    "COMPANY ": "Aspira Women's Health",
    "LINK": "https://aspirawh.com/ovawatch/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Ovarian",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "CA-125, 6 others",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Malignancy Assessment (Primary)",
    "CANCER TYPE": "Ovarian",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Ova1Plus",
    "COMPANY ": "Aspira Women's Health",
    "LINK": "https://aspirawh.com/ova1plus/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Ovarian",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "CA-125, 6 others",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Malignancy Assessment (Primary)",
    "CANCER TYPE": "Ovarian",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "CNSide",
    "COMPANY ": "Biocept",
    "LINK": "https://biocept.com/cnside-assay/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "CNS (Central Nervous System)",
    "FLUID TYPE": "CSF",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "CTC",
    "Appl. Genes": "",
    "TARGET": "CTC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Malignancy Assessment (metastasis)",
    "CANCER TYPE": "CNS mets (from carcinoma/melanoma)",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "NodifyLung",
    "COMPANY ": "Biodesix",
    "LINK": "https://www.biodesix.com/our-tests/nodify-lung",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "LG3BP,C163A, biomarkes",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Maignancy Assessment (Primary + met)",
    "CANCER TYPE": "Lung mets",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "IQlung",
    "COMPANY ": "Biodesix",
    "LINK": "https://www.biodesix.com/our-tests/iq-lung",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung (Non-Small Cell)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Txt Guidance (Gene Based)",
    "CANCER TYPE": "NSCLC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Boston Gene Liquid Biopsy",
    "COMPANY ": "Boston Gene",
    "LINK": "https://bostongene.com/providers/bostongene-liquid-biopsy/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "Yes",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "",
    "TEST TYPE": "",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "CELLSearch",
    "COMPANY ": "Menarini Silicon Biosystems",
    "LINK": "https://www.cellsearchctc.com/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "CTC",
    "Appl. Genes": "",
    "TARGET": "CTC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD ( met recurrance)",
    "CANCER TYPE": "Breast, Prostate, CRC mets",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "CELLSearch CMMC",
    "COMPANY ": "Menarini Silicon Biosystems",
    "LINK": "https://www.siliconbiosystems.com/en-us/Oncology/Multiple-Myeloma",
    "Action (Coded)": "MRD (response)",
    "Cancer Type (Coded)": "Mult. Myeloma",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "CMMC",
    "Appl. Genes": "",
    "TARGET": "CMMC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (txt efficacy)",
    "CANCER TYPE": "Multiple Myeloma",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Advantect",
    "COMPANY ": "ClearNote Health (Bluestar Genomics)",
    "LINK": "https://www.avantect.com/avantect-test/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Pancreatic",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "cfDNA",
    "Appl. Genes": "",
    "TARGET": "cfDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection ",
    "CANCER TYPE": "Pancreatic",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "IsoPSA",
    "COMPANY ": "Cleveland Diagnostics",
    "LINK": "https://www.clevelanddx.com/isopsa-testing",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "PSA proteins (from cancer cells)",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Biopsy guidance ",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "InsureONE",
    "COMPANY ": "ClinicalGenomics",
    "LINK": "https://insuretest.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Stool",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "Blood in Stool",
    "Appl. Genes": "",
    "TARGET": "Blood in stool",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection (FIT, primary)",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "UROAMP",
    "COMPANY ": "Convergent Genomics",
    "LINK": "https://convergentgenomics.com/products-uroamp/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Bladder",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "ctDNA (?)",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (recurrance)",
    "CANCER TYPE": "Bladder",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "TruBlood",
    "COMPANY ": "Datar Cancer Genetics",
    "LINK": "https://trublood360.com/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "CTC",
    "Appl. Genes": "",
    "TARGET": "CTC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Lung, Prostate, Pancreas, CNS, Ovarian",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "TruBlood only in UK",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "RadTox",
    "COMPANY ": "DiaCarta",
    "LINK": "https://www.diacarta.com/products/radtox",
    "Action (Coded)": "MRD (response)",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "cfDNA",
    "Appl. Genes": "",
    "TARGET": "cfDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "5 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Monitor throughout txt",
    "CANCER TYPE": "Multiple",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ColoScape",
    "COMPANY ": "DiaCarta",
    "LINK": "https://www.diacartaclinicallab.com/fit-tests-diacartas-coloscape/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "cfDNA (?)",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Action guidance (if FIT positive but don't want colonoscopy)",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "OncUria",
    "COMPANY ": "DiaCarta",
    "LINK": "https://www.diacartaclinicallab.com/oncuria/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Bladder",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Risk assess (very limited usage)",
    "CANCER TYPE": "Bladder",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Prostate Cancer Test",
    "COMPANY ": "Diagnolita",
    "LINK": "https://www.diagnolita.lt/en/tests/prostate-cancer-biomarker-test/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "Lithuania",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "CancerRadar",
    "COMPANY ": "EarlyDx",
    "LINK": "https://earlydx.com/product/cancer-radar/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "cfDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection  ",
    "CANCER TYPE": "Multiple  ",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ColoPlex",
    "COMPANY ": "New Day Diagnostics",
    "LINK": "https://newdaydiagnostics.com/coloplex/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "Non-US use",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ColoPlex Plus",
    "COMPANY ": "New Day Diagnostics",
    "LINK": "https://newdaydiagnostics.com/wp-content/uploads/2024/02/ColoPlex-Plus-Sell-Sheet.pdf",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "cfDNA (SEPT9)",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ColoHealth",
    "COMPANY ": "New Day Diagnostics",
    "LINK": "https://newdaydiagnostics.com/wp-content/uploads/2023/11/ColoHealthSalesSheet.pdf",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "InSure ONE",
    "COMPANY ": "Enterix",
    "LINK": "https://insuretest.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Toilet Water",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "Blood in Stool",
    "Appl. Genes": "",
    "TARGET": "Blood in Stool",
    "Dev. Stage": "",
    "Turnaround Time ": "14 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection (FIT using toilet bowl water)",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Cologuard",
    "COMPANY ": "Exact Sciences",
    "LINK": "https://www.cologuard.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Stool",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "Blood in Stool",
    "Appl. Genes": "",
    "TARGET": "Blood in stool, genetic markers",
    "Dev. Stage": "",
    "Turnaround Time ": "14 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection (FIT + genetics)",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "oncoguard liver",
    "COMPANY ": "Exact Sciences",
    "LINK": "https://www.oncoguardliver.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Liver ",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "MDMs ",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "HCC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ExoDx Prostate",
    "COMPANY ": "ExomeDx",
    "LINK": "https://www.exosomedx.com/patients/exodx-prostate-test",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Risk Assessment (biopsy)",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "FoundationOne Liquid CDx",
    "COMPANY ": "Foundation Medicine Inc",
    "LINK": "https://www.foundationmedicine.com/test/foundationone-liquid-cdx",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Solid Tumors",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "Yes",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Txt Guidance (Gene Based)",
    "CANCER TYPE": "Solid Tumor",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "EarlyTect Colon",
    "COMPANY ": "Genomictree",
    "LINK": "https://genomictree.com/ko/products/earlytect-colon-cancer/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Stool",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "FDA trial coming soon",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "South Korea",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "EarlyTect Lung",
    "COMPANY ": "Genomictree",
    "LINK": "https://genomictree.com/ko/products/earlytect-lung-cancer/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "methylation of PCDHGA12",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "Lung",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "South Korea",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "EarlyTectBladder",
    "COMPANY ": "Genomictree",
    "LINK": "https://genomictree.com/ko/products/earlytect-bladder-cancer/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Bladder",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection + MRD",
    "CANCER TYPE": "Bladder",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Glycanostics Test",
    "COMPANY ": "Glycanostics",
    "LINK": "https://glycanostics.com/our-products/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "Glycans (on proteins)",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Risk Assessment (biopsy)",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "EU",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Guardant360 CDx",
    "COMPANY ": "Guardant Health",
    "LINK": "https://www.guardantcomplete.com/guardant-portfolio/cdx?utm_source=google&utm_medium=search&utm_campaign=Guardant360_HCP_GGL_BRND_Brand_AWA_SEA_EXTM_US_EN%20KW%20-%20SP%20BR_ALL&utm_term=guardant%20health&utm_content=search&gad_source=1&gclid=Cj0KCQiAoKeuBhCoARIsAB4WxtdsbGLJiQDJImSnXmmcqJeZnrhFNKrhj_vAMqb887fbGNuF_WHfuxwaAnOiEALw_wcB&gclsrc=aw.ds",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "Yes",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "7",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Action Guidance",
    "CANCER TYPE": "Lung, Breast",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "GuardantReveal",
    "COMPANY ": "Guardant Health",
    "LINK": "https://www.guardantcomplete.com/guardant-portfolio/reveal?utm_source=google&utm_medium=search&utm_campaign=Guardant360_HCP_GGL_BRND_Brand_AWA_SEA_EXTM_US_EN%20KW%20-%20SP%20BR_ALL&utm_term=guardant%20health&utm_content=search&gad_source=1&gclid=Cj0KCQiAoKeuBhCoARIsAB4WxtdsbGLJiQDJImSnXmmcqJeZnrhFNKrhj_vAMqb887fbGNuF_WHfuxwaAnOiEALw_wcB&gclsrc=aw.ds",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "CRC, Lung, Breast",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Guardant360 Response",
    "COMPANY ": "Guardant Health",
    "LINK": "https://www.guardantcomplete.com/guardant-portfolio/response?utm_source=google&utm_medium=search&utm_campaign=Guardant360_HCP_GGL_BRND_Brand_AWA_SEA_EXTM_US_EN%20KW%20-%20SP%20BR_ALL&utm_term=guardant%20health&utm_content=search&gad_source=1&gclid=Cj0KCQiAoKeuBhCoARIsAB4WxtdsbGLJiQDJImSnXmmcqJeZnrhFNKrhj_vAMqb887fbGNuF_WHfuxwaAnOiEALw_wcB&gclsrc=aw.ds",
    "Action (Coded)": "MRD (response)",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA   ",
    "Dev. Stage": "",
    "Turnaround Time ": "14",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (therapy response)",
    "CANCER TYPE": "",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Guardant360",
    "COMPANY ": "Guardant Health",
    "LINK": "https://www.guardantcomplete.com/guardant-portfolio/360?utm_source=google&utm_medium=search&utm_campaign=Guardant360_HCP_GGL_BRND_Brand_AWA_SEA_EXTM_US_EN%20KW%20-%20SP%20BR_ALL&utm_term=guardant%20health&utm_content=search&gad_source=1&gclid=Cj0KCQiAoKeuBhCoARIsAB4WxtdsbGLJiQDJImSnXmmcqJeZnrhFNKrhj_vAMqb887fbGNuF_WHfuxwaAnOiEALw_wcB&gclsrc=aw.ds",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Solid Tumors",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "10",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Galleri test",
    "COMPANY ": "GRAIL",
    "LINK": "https://www.galleri.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "cfDNA",
    "Appl. Genes": "",
    "TARGET": "cfDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "Multiple",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "HelioLiver",
    "COMPANY ": "Helio Genomics",
    "LINK": "https://helioliver.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Liver ",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "cfDNA, proteins",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "HCC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "PancraGEN",
    "COMPANY ": "Interpace Biosciences (formerly known as Interpace Diagnostics)",
    "LINK": "https://pancragen.com/how-it-works/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Pancreatic",
    "FLUID TYPE": "Cyst Fluid",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Risk Assess (primary)",
    "CANCER TYPE": "Pancreatic",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "LucenceINSIGHT",
    "COMPANY ": "Lucence",
    "LINK": "https://insight.lucence.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "18 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "Multiple",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "LiquidHALLMARK",
    "COMPANY ": "Lucence",
    "LINK": "https://www.lucence.com/liquid-biopsy/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Genomic Profiling",
    "CANCER TYPE": "Multiple",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "LungLB Test",
    "COMPANY ": "LungLife AI",
    "LINK": "https://lunglifeai.com/lunglb/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "CTC",
    "Appl. Genes": "",
    "TARGET": "CTC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Risk Assessment (indeterminate pulm nodule)",
    "CANCER TYPE": "Lung",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Mitomic Prostate Test",
    "COMPANY ": "MDNA Life Sciences",
    "LINK": "https://mdnalifesciences.com/mitomic-tests/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "MDNA",
    "Appl. Genes": "",
    "TARGET": "MDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Mitomic Endometriosis Test",
    "COMPANY ": "MDNA Life Sciences",
    "LINK": "https://mdnalifesciences.com/mitomic-tests/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Endometrial",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "MDNA",
    "Appl. Genes": "",
    "TARGET": "MDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Endometrial",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Select mdx",
    "COMPANY ": "MDxHealth",
    "LINK": "https://mdxhealth.com/select-mdx-for-physicians/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Mercy Halo Test",
    "COMPANY ": "Mercy BioAnalytics",
    "LINK": "https://mercybio.com/the-mercy-halo-test/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "EV",
    "Appl. Genes": "",
    "TARGET": "EV",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Lung, Ovarian",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "OncobiotaLUNG",
    "COMPANY ": "Micronoma",
    "LINK": "https://micronoma.com/lung-cancer/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Risk Assessment (indeterminate pulm nodule)",
    "CANCER TYPE": "Lung",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "MICheck Prostate",
    "COMPANY ": "Minomic",
    "LINK": "https://minomic.com/micheck-prostate/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "Australia",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "miR Sentinel Prostate",
    "COMPANY ": "miR Scientific",
    "LINK": "https://www.mirscientific.com/mir-advantage",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "GASTROClear",
    "COMPANY ": "MiRXES",
    "LINK": "https://gastroclear.mirxes.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Gastric",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "mRNA",
    "Appl. Genes": "",
    "TARGET": "mRNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Gastric",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ClarityDx Prostate",
    "COMPANY ": "Nanostics",
    "LINK": "https://www.nanosticsdx.com/clarity-dx-prostate/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Signatera",
    "COMPANY ": "Natera",
    "LINK": "https://www.natera.com/oncology/signatera-advanced-cancer-detection/patients/#pg-menu-tabs",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Solid Tumors",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD (recurrance)",
    "CANCER TYPE": "Solid Tumors",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "NavDx",
    "COMPANY ": "Naveris",
    "LINK": "https://naveris.com/what-is-navdx/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Head/Neck",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "TTMV DNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "HPV-driven Head, Neck",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "InVisionFirst-Lung",
    "COMPANY ": "NeoGenomics",
    "LINK": "https://neogenomics.com/invisionfirstr-lung",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung (Non-Small Cell)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "7 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "NSCLC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Galeas Bladder",
    "COMPANY ": "Nonacus",
    "LINK": "https://galeas.net/galeas-bladder/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Bladder",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Risk Assessment",
    "CANCER TYPE": "Bladder",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Colox",
    "COMPANY ": "Novigenix",
    "LINK": "https://novigenix.com/colox-solution/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "14 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Bladder EpiCheck",
    "COMPANY ": "Nucleix",
    "LINK": "https://nucleix.com/us/bladder-epicheck/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Bladder",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "Yes",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "non-muscle bladder cancer",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Lung EpiCheck",
    "COMPANY ": "Nucleix",
    "LINK": "https://nucleix.com/us/lung-epicheck-3/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "No",
    "CLIA cert?": "",
    "Target (Coded)": "ctDNA",
    "Appl. Genes": "",
    "TARGET": "ctDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Lung",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "OncoSELECT",
    "COMPANY ": "OncoDNA",
    "LINK": "https://oncodna.com/for-laboratories/liquid-biopsy-oncoselect/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Profiling",
    "CANCER TYPE": "",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "Germany",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "4Kscore Test",
    "COMPANY ": "OPKO",
    "LINK": "https://4kscore.com/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Risk Assessment",
    "CANCER TYPE": "Prostate",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Cxbladder",
    "COMPANY ": "Pacific Edge Diagnostics USA",
    "LINK": "https://www.pacificedgedx.com/products/cxbladder/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Bladder",
    "FLUID TYPE": "Urine",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "3 days",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Bladder",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "NeXT Personal Dx",
    "COMPANY ": "Personalis",
    "LINK": "https://www.personalis.com/for-clinicians/next-personal-dx/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "MRD",
    "CANCER TYPE": "Lung, Breast",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "PredicineBEACON",
    "COMPANY ": "Predicine",
    "LINK": "https://www.predicine.com/solutions-overview/predicinebeacon/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "AdnaTest BreastCancer",
    "COMPANY ": "QIAGEN",
    "LINK": "https://www.qiagen.com/us/products/discovery-and-translational-research/exosomes-ctcs/circulating-tumor-cells/adnatest-breast-cancer?catno=395012",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Breast",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "CTC",
    "Appl. Genes": "",
    "TARGET": "CTC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Breast",
    "TEST TYPE": "LB",
    "Cost": "1,152",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "AdnaTest LungCancer",
    "COMPANY ": "QIAGEN",
    "LINK": "https://www.qiagen.com/us/products/discovery-and-translational-research/exosomes-ctcs/circulating-tumor-cells/adnatest-lungcancer",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "CTC",
    "Appl. Genes": "",
    "TARGET": "CTC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Lung ",
    "TEST TYPE": "LB",
    "Cost": "1,326",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "AdnaTest ColonCancer",
    "COMPANY ": "QIAGEN",
    "LINK": "https://www.qiagen.com/us/products/discovery-and-translational-research/exosomes-ctcs/circulating-tumor-cells/adnatest-colon-cancer",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Colon",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "CTC",
    "Appl. Genes": "",
    "TARGET": "CTC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Colon",
    "TEST TYPE": "LB",
    "Cost": "1,152",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "AdnaTest ProstateCancer",
    "COMPANY ": "QIAGEN",
    "LINK": "https://www.qiagen.com/us/products/discovery-and-translational-research/exosomes-ctcs/circulating-tumor-cells/adnatest-prostate-cancer",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Prostate",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "CTC",
    "Appl. Genes": "",
    "TARGET": "CTC",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Prostate ",
    "TEST TYPE": "LB",
    "Cost": "1,152",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Resolution ctDx FIRST",
    "COMPANY ": "Resolution Bioscience ",
    "LINK": "https://www.resolutionbio.com/assays/Resolution-ctDx-FIRST.html",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung (Non-Small Cell)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "NSCLC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Resolution ctDX Lung",
    "COMPANY ": "Resolution Bioscience ",
    "LINK": "https://www.resolutionbio.com/assays/Resolution-ctDx-Lung.html",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung (Non-Small Cell)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Txt Guidance (Gene Based)",
    "CANCER TYPE": "Lung",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Aristotle",
    "COMPANY ": "StageZero Life Sciences",
    "LINK": "https://www.stagezerolifesciences.com/aristotle-test.html",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "Yes",
    "Target (Coded)": "mRNA",
    "Appl. Genes": "",
    "TARGET": "mRNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "Multiple",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "ColonSentry",
    "COMPANY ": "StageZero Life Sciences",
    "LINK": "https://www.stagezerolifesciences.com/colonsentry.html",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "Yes",
    "Target (Coded)": "mRNA",
    "Appl. Genes": "",
    "TARGET": "mRNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Signal-C",
    "COMPANY ": "Universal Diagnostics",
    "LINK": "https://www.universaldx.com/multicancer-platform",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "cfDNA",
    "Appl. Genes": "",
    "TARGET": "cfDNA",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "CRC",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "Nu-Q Cancer",
    "COMPANY ": "Volition",
    "LINK": "https://volition.com/nu-q",
    "Action (Coded)": "MRD (response)",
    "Cancer Type (Coded)": "Multiple",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "Circ. Nucleosomes",
    "Appl. Genes": "",
    "TARGET": "Circ. Nucleosomes",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "EU",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "AlphaLiquid Screening",
    "COMPANY ": "IMBdx",
    "LINK": "https://www.imbdx.com/eng/about/screening.php",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "",
    "FLUID TYPE": "Blood",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "cfDNA",
    "Appl. Genes": "",
    "TARGET": "cfDNA",
    "Dev. Stage": "Non-USA",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "Early Detection",
    "CANCER TYPE": "",
    "TEST TYPE": "LB",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "",
    "COMPANY ": "",
    "LINK": "",
    "Action (Coded)": "",
    "Cancer Type (Coded)": "",
    "FLUID TYPE": "",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "",
    "TEST TYPE": "",
    "Cost": "",
    "Location": "",
    "KEY": ""
  },
  {
    "﻿TEST NAME": "",
    "COMPANY ": "",
    "LINK": "",
    "Action (Coded)": "",
    "Cancer Type (Coded)": "",
    "FLUID TYPE": "",
    "": "",
    "FDA Appr?": "",
    "CLIA cert?": "",
    "Target (Coded)": "",
    "Appl. Genes": "",
    "TARGET": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Notes": "",
    "Requirements": "",
    "ACTION": "",
    "CANCER TYPE": "",
    "TEST TYPE": "",
    "Cost": "",
    "Location": "",
    "KEY": ""
  }
]